eventsbot – online event registration
SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017  
Mon, May 22, 2017 at 8:30 am to Tue, May 23, 2017 at 5:30 pm GMT
Date, Time and Location
Mon, May 22, 2017 at 8:30 AM GMT
Tue, May 23, 2017 at 5:30 PM GMT
Location & Address
Copthorne Tara Hotel
Scarsdale Place, Kensington
United Kingdom-W8 5SY

Maps        Weather

Share/tag this pageShare/tag this page
Add to My CalendarAdd to My Calendar
Register Now
Register by 31 Jan: GBP 1099, Register by 28 Feb: GBP 1299, Register by 31 Mar: GBP 1399, Standard Price: GBP 1499
Event Details
In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs).
With this continued development, SMi has been receptive to the steadily increasing market growth and have launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place 22nd – 23rd May in London, UK.
The conference programme has been produced to enable delegates to gain knowledgeable insight on how to develop highly potent APIs more efficiently, safely and more cost effectively than before. Whether your area of expertise is in process development, scale up, occupational safety or outsourcing, this two day conference is certain to equip you with a wealth of actionable insights.
Alessandro Brigo, Toxicology Project Leader, Pharmaceutical Sciences
Andreas Flueckiger, Chief Occupational Health Officer, Roche
Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca
Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Hungary
Jack Brown, Senior Principal Scientist, Boehringer Ingelheim
James Evans, Vice President CMC, NuCana BioMed
Jason Hamm, Director of Chemical Development Operations, Bristol-Myers Squibb
Richard Denk, Head Sales Containment, SKAN AG
Address the challenges of working with HPAPIs and approaches to scale-up
Discuss strategies for CMO selection and solutions to better communication and transfer
Hear about Teva API’s Operational Excellence and QC Lab Transformation
Gain insight into the ISPE contamination Manual covering containment issues from the PDE/ OEL to life cycle
Learn about Health Hazard Assessment Classifications and the toxicological criteria of potent compounds
Category: Conferences | Science, Health & Medicine | Pharmaceuticals
Speakers: Pharmaceutical Sciences, Roche, AstraZeneca, Gedeon Richter Hungary, Boehringer Ingelheim, NuCana BioMed, Bristol-Myers Squibb, SKAN AG and many more!
Event Hosted By
powered by
eventsbot Home
This web page was published using www.eventsbot.comOnline Event Registration and Management Service. If you have any issues/queries related to this event then please contact event organizer directly. You can also Register, Publish, Manage and Promote your events using eventsbot.
©2017 eventsbot. All rights reserved.